As of January 22, 2025, Monopar Therapeutics (MNPR) has a market cap of $0.21 billion USD. According to our data, Monopar Therapeutics is ranked No.7081 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.21 B |
53.05%
|
Dec 31, 2024 | $0.13 B |
1,194.12%
|
Dec 29, 2023 | $10.37 M |
-85.65%
|
Dec 30, 2022 | $72.31 M |
-26.17%
|
Dec 31, 2021 | $97.95 M |
-47.55%
|
Dec 31, 2020 | $0.19 B |
-63.13%
|
Dec 31, 2019 | $0.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
CytomX Therapeutics
CTMX
|
$65.57 M |
0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Agenus
AGEN
|
$86.42 M |
0.000 M
|
USA
|
Market Cap | = | MNPR Stock Price | * | MNPR Shares Outstanding |
= | $33.67 | * | 6.10 M | |
= | $0.21 B |